2025 China Breast Augmentation Market Revenue Opportunities Report
Description
The 2025 China Breast Augmentation Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Breast Augmentation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in China’s breast augmentation market include AbbVie (Allergan), Johnson & Johnson (Mentor), Sientra, and GC Aesthetics. AbbVie, after acquiring Allergan, holds a significant global market share (23%) and has a broad product portfolio, though it has faced regulatory challenges related to implant safety. Johnson & Johnson's Mentor division commands around 21% of the global breast implant market and is known for its extensive distribution and R&D investments. Sientra, a smaller US-based specialist, reported revenues of $46.4 million in 2019 and focuses on innovative implant technologies.
GC Aesthetics has recently launched its premium YOUTHLY™ brand in China, featuring advanced breast implant options like The Round Collection™ and Luna XT™, positioning itself strongly in China’s fast-growing aesthetic market, which is projected to grow at 15% annually. These companies leverage innovation, clinical data, and strategic partnerships to increase their footprint in China, which ranked as the world's second-largest aesthetic procedures market in 2025, with breast augmentation growing significantly amid rising consumer demand and advanced surgical expertise.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Breast Augmentation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in China’s breast augmentation market include AbbVie (Allergan), Johnson & Johnson (Mentor), Sientra, and GC Aesthetics. AbbVie, after acquiring Allergan, holds a significant global market share (23%) and has a broad product portfolio, though it has faced regulatory challenges related to implant safety. Johnson & Johnson's Mentor division commands around 21% of the global breast implant market and is known for its extensive distribution and R&D investments. Sientra, a smaller US-based specialist, reported revenues of $46.4 million in 2019 and focuses on innovative implant technologies.
GC Aesthetics has recently launched its premium YOUTHLY™ brand in China, featuring advanced breast implant options like The Round Collection™ and Luna XT™, positioning itself strongly in China’s fast-growing aesthetic market, which is projected to grow at 15% annually. These companies leverage innovation, clinical data, and strategic partnerships to increase their footprint in China, which ranked as the world's second-largest aesthetic procedures market in 2025, with breast augmentation growing significantly amid rising consumer demand and advanced surgical expertise.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
